Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Preventive Healthcare Services

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Levels of Health Promotion and Illness Prevention

Levels of Health Promotion and Illness Prevention

Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Reevaluation of cytological smears in patients with cervical cancer. Regional quality assurance program with the cooperation of the Austrian Society for Cytology, the Carinthian Medical Association and the Carinthian Ministry of Health].

Der Pathologe·2007

Same author

Small-cell carcinoma of the uterus and the vagina: experience with ten patients.

Archives of gynecology and obstetrics·2004

Same author

Cytopathology in Austria.

Cytopathology : official journal of the British Society for Clinical Cytology·2004

Same author

Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density.

Gynecologic oncology·2004

Same author

Immunohistochemical expression of laminin-5 in cervical intraepithelial neoplasia.

Gynecologic oncology·2003

Same author

Lack of impact of platinum dose intensity on the outcome of ovarian cancer patients. 10-year results of a prospective randomised phase III study comparing carboplatin-cisplatin with cyclophosphamide-cisplatin.

European journal of cancer (Oxford, England : 1990)·2003

Search research articles

Related Experiment Video

Updated: Jun 20, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

[Cervical cancer screening: past--present--future].

G Breitenecker¹

¹Ehemals Abteilung Gynäkopathologie und Zytologie, Pathologisches Institut der Medizinischen Universität Wien, Wien, Osterreich. gerhard.breitenecker@univie.ac.at

|September 17, 2009

Summary

Cervical cytology has significantly reduced cervical cancer mortality, but challenges in coverage and smear quality persist. New technologies show limited advantages, and while HPV testing offers promise, cytology remains essential for early detection.

Related Experiment Videos

Last Updated: Jun 20, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

Area of Science:

Gynecologic Oncology
Public Health Screening
Infectious Disease Epidemiology

Context:

Cervical cytology has historically reduced cervical cancer mortality by 75% since the 1960s.
Current screening methods face limitations in coverage and smear quality, impacting effectiveness.
Organized screening programs generally achieve higher coverage than opportunistic ones.

Purpose:

To evaluate the current state and future prospects of cervical cancer screening methods.
To assess the role of human papillomavirus (HPV) testing and vaccination in cervical cancer prevention.
To highlight the continued importance of high-quality cervical cytology.

Summary:

Despite successes, cervical cytology is imperfect due to coverage and quality issues. New technologies like liquid-based cytology and automation have not proven cost-effective.
Human papillomavirus (HPV) testing shows promise, particularly in organized screening and as a triage test for equivocal results, but primary HPV screening alone is not recommended for opportunistic settings.
While HPV vaccination is a hopeful future tool, its long-term impact is unknown, and current vaccines do not cover all oncogenic types. High-quality cervical cytology remains crucial for early detection.

Impact:

Highlights the persistent need for quality improvement in cervical cytology programs.
Identifies HPV testing as a valuable adjunct and triage tool in specific screening contexts.
Emphasizes that cervical cytology will remain a cornerstone of cervical cancer control for the foreseeable future.